Equity Plans (Tables)

9 Months Ended

May 30, 2025

Share-Based Payment Arrangement [Abstract]

Summary of Aggregate Restricted Award Activity and Assumptions

Restricted Award activity was as follows:

	Three Months Ended				Nine Months Ended
	May 30, 2025		May 31, 2024		May 30, 2025		May 31, 2024
Restricted awards granted	1,323		1,213		2,006		1,837
Weighted-average grant date fair value per share	$	17.09	$	19.93	$	18.35	$	22.47
Aggregate vesting date fair value of shares vested	$	6,091	$	6,629	$	25,768	$	25,584

Schedule of Share Based Compensation Expense Allocation

Share-based compensation expense for our continuing operations was as follows:

	Three Months Ended				Nine Months Ended
	May 30, 2025		May 31, 2024		May 30, 2025		May 31, 2024
Share-based compensation expense by caption:
Cost of sales	$	1,393	$	1,760	$	4,812	$	5,301
Research and development	1,531		1,968		4,818		5,382
Selling, general and administrative	7,327		7,464		23,732		22,371
	$	10,251	$	11,192	$	33,362	$	33,054